Compare Multi Prima Sejahtera Tbk (LPIN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multi Prima Sejahtera Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Multi Prima Sejahtera Tbk trades at Rp428 (market cap 183.6B, 77K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multi Prima Sejahtera Tbk is the larger of the two by market cap. Which is the better fit depends on your goals.
| LPIN | SCPI | |
|---|---|---|
Market Cap | 183.6B | 104.4B |
Volume | 77K | — |
Lot | 770 | — |
Turnover | 33.12M | — |
Average Price | 430.17 | — |
Value | 33.12M | — |
Indicative Equilibrium Price | 434 | — |
Indicative Equilibrium Volume | 7 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multi Prima Sejahtera Tbk
PT Multi Prima Sejahtera Tbk was established in January 7, 1982, PT Lippo Industries is licensed producer of spark-plug under the Champion trade mark. It has 7 subsidiaries In 1996, it joint venture with Kwan Yang Motor Company, Taiwan to established a motorcycle manufacturing. And on AEGM on June 27th 2001, the meeting decide to change the company's name to Multi Prima Sejahtera Tbk.
Read more on LPIN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
